icatolimab,toripalimab
coherus biosciences,shanghai junshi bioscience
['icatolimab', 'toripalimab', 'junshi']
junshi biosciences highlights pipeline advances in immuno-oncology through nearly 40 data presentations of icatolimab and toripalimab at asco 2022 
BioCalifornia is committed to the growth of life sciences, and commercialization of discoveries to improve human health, the environment, and sustainability.